Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mini-Transplant and DLI for Refractory Metastatic Solid Tumors
NCT00001880Phase 2Terminated
- Sponsor
- National Heart, Lung, and Blood Institute
- Start
- Mar 1999
- Primary completion
- Aug 2008
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of allogeneic peripheral blood progenitor cells in metastatic solid tumors, sponsored by National Heart, Lung, and Blood Institute. Started Mar 1999; status: terminated.
02
Drugs
allogeneic peripheral blood progenitor cells
03
Conditions
metastatic solid tumors
Beyond the preview
Go deeper on NCT00001880.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00001880.